Lien T Ngo Selected Research

T-Cell Antigen Receptors (T-Cell Receptor)

1/2022	Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.
1/2022	Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.
1/2021	Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells.
1/2021	Identification and Validation of T-cell Receptors Targeting RAS Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy.
11/2008	Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lien T Ngo Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 11/2005
2	Melanoma (Melanoma, Malignant) 05/2015 - 11/2005
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Liver Diseases (Liver Disease) 05/2015
1	Fever (Fevers) 05/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2015
1	Lymphopenia (Lymphocytopenia) 05/2006
1	Inflammation (Inflammations) 03/2006

Drug/Important Bio-Agent (IBA)

5	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 11/2008
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 11/2005
3	AntigensIBA 01/2022 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2008
2	Peptides (Polypeptides)IBA 03/2006 - 11/2005
1	HLA-A Antigens (HLA-A)IBA 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2019
1	Interleukin-2 (IL2)IBA 05/2015
1	Interleukin-12 (IL 12)IBA 05/2015
1	Chimeric Antigen ReceptorsIBA 02/2015
1	Interleukin-7 (Interleukin 7)IBA 05/2006
1	EmulsionsIBA 03/2006
1	HLA-A*02:01 antigenIBA 11/2005
1	Biomarkers (Surrogate Marker)IBA 11/2005
1	EpitopesIBA 11/2005
1	VaccinesIBA 11/2005

Therapy/Procedure

7	Immunotherapy 01/2022 - 11/2008
1	Therapeutics 01/2022
1	Drug Therapy (Chemotherapy) 02/2015